Second to its effect on HDAC3 phosphorylation, targeting of CHROMR promoted apoptotic cell death and reduced mitogen-activated protein kinase (MAPK) and protein kinase B (AKT) signaling, pathways essential for DLBCL growth. Here, AKT1 is linked to diffuse large B-cell lymphoma.